The study, published in the journal Cell Reports, identifies vulnerabilities that could provide a target for therapeutic drugs already being studied for several different types of cancer. It was led by Dr. Caius Radu, a UCLA professor of molecular and medical pharmacology, and Dr. Timothy Donahue, a pancreatic cancer surgeon. Read more . . .
Research led by scientists at the UCLA Jonsson Comprehensive Cancer Center provides new insights into molecular “crosstalk” in pancreas cancer cells.